Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors
Clinical trial NCT00002361 · COMPLETED
Trial details
- NCT number
- NCT00002361
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.